Mediastinal lymph nodes are small immune-system glands located in the mediastinum, the central compartment of the chest between the lungs that contains the heart, trachea, esophagus, and major blood vessels. These nodes filter lymph fluid draining from the lungs, pleura, and other chest structures, and they are a common site where lung cancer and mesothelioma can spread.
Origin
The word "mediastinum" comes from the medieval Latin mediastinus, meaning "in the middle," referring to the central position of this anatomical space. "Lymph" derives from the Latin lympha (clear water), describing the pale fluid these nodes filter.
Significance in Asbestos Context
For patients with mesothelioma or asbestos-related lung cancer, mediastinal lymph node status is one of the most important factors in determining stage, treatment options, and prognosis. If imaging or biopsy shows cancer in these nodes, surgical options such as extrapleural pneumonectomy or pleurectomy/decortication may be limited or off the table, and treatment may shift toward chemotherapy, immunotherapy, or radiation. Patients should ask their oncologist whether mediastinal nodes were evaluated by PET-CT, EBUS (endobronchial ultrasound), or mediastinoscopy, and what the N-stage (N0, N1, N2, N3) is. This staging detail is often important documentation in a legal claim because it affects damages related to life expectancy and treatment burden.
Example Sentence
The PET scan showed uptake in the mediastinal lymph nodes, so the thoracic surgeon ordered an EBUS biopsy before deciding whether surgery was still an option for the mesothelioma.
Related Terms
Mesothelioma Staging, EBUS, Mediastinoscopy, Pleura, Lymphatic Spread, Extrapleural Pneumonectomy
Notes
- Ask your oncologist for the specific N-stage assigned to your cancer and request that the radiology and pathology reports describing mediastinal node involvement be included in your medical records.
- If surgery is being considered, ask whether a mediastinoscopy or EBUS-guided biopsy will be performed first to confirm or rule out node involvement. Imaging alone can be misleading.
- Preserve copies of all PET-CT scans, biopsy reports, and staging documentation; these directly support both treatment planning and the medical evidence in an asbestos claim.
- Node involvement can change over time; if you are being monitored or treated, track interval scans and ask how node status is evolving.
In the research library
21 studies in our medical research library mention Mediastinal Lymph Nodes in the title or abstract. Among the most cited:
- The prevalence of enlarged mediastinal lymph nodes in asbestos-exposed individuals: a CT studyC. Sampson, D.M. Hansell, 1992 · Clinical Radiology · cited 14 times
- Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesotheliomaD.J. Sugarbaker, G.M. Strauss, T.J. Lynch, et al, 1993 · Journal of Clinical Oncology · cited 185 times
- Talc slurry pleurodesis. Pleural fluid and histologic analysisL. Kennedy, R.A. Harley, S.A. Sahn, et al, 1995 · Chest · cited 88 times
- Multi-walled carbon nanotubes translocate into the pleural cavity and induce visceral mesothelial proliferation in ratsJ. Xu, M. Futakuchi, H. Shimizu, et al, 2012 · Cancer Science · cited 76 times
- Computed tomography of malignant pleural mesotheliomaD.C. Grant, S.E. Seltzer, K.H. Antman, et al, 1983 · Journal of Computer Assisted Tomography · cited 36 times
The journals that publish most on it: Cancer Science (1), Respirology Case Reports (1), Curēus (1).
Category: Anatomy & Physiology · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.